Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Cancer|December 1, 1976
Combination chemotherapy of advanced lung cancer: a randomized trialH H Hansen, O S Selawry, R Simon, et al.
Chest|August 1, 1977
Desquamative interstitial pneumonia-like reaction accompanying pulmonary lesionsC W Bedrossian, C Kuhn, M A Luna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancerH M Dhingra, M Valdivieso, D T Carr, et al.
Cardiorenal Medicine|May 20, 2016
Serum Cortisol-to-Cortisone Ratio and Blood Pressure in Severe Obesity before and after Weight LossJames B Byrd, Amy E Rothberg, Robert Chomic, et al.
Chest|August 1, 1979
Tuberculosis in Oriental immigrants: a study in military dependentsR B Byrd, D E Fisk, R A Roethe, et al.
Journal of Hip Preservation Surgery|April 18, 2025
Spinal versus general anesthesia for hip arthroscopy-a pandemic (COVID) and epidemic (opioid) driven studyJ W Thomas Byrd, Kay S Jones, Nicole Dwyer, et al.
Investigational New Drugs|September 1, 1988
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinomaP Y Holoye, D T Carr, H M Dhingra, et al.
American Journal of Clinical Oncology|October 1, 1984
Prospective evaluation of thymosin fraction V immunotherapy in patients with non-small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapyA Y Bedikian, Y Z Patt, W K Murphy, et al.
Pharmacogenetics and Genomics|July 14, 2010
Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedemaAlencia V Woodard-Grice, Amelia C Lucisano, James B Byrd, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Preclinical assessment of 90Y-labeled monoclonal antibody CO17-1A, a potential agent for radioimmunotherapy of colorectal carcinomaL C Washburn, Y C Lee, T T Sun, et al.
Pageof 9